Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review

M. E. SOCIAS ; M. KARAMOUZIAN ; S. PARENT ; J. BARLETTA ; K. BIRD ; L. TI | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

Background: Despite the key role that people who inject drugs (PWID) play in the hepatitis C virus (HCV) epidemic, HCV treatment rates among this population have been historically low. Integrated models of HCV and substance use care have the pot[...]

Plus d'info

Ajouter à la sélection

Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy

K. BIRD ; M. E. SOCIAS ; L. TI | 2018
Dans International Journal of Drug Policy (Vol.59, September 2018) Article : Périodique

As new, more tolerable and effective hepatitis C virus (HCV) treatments are available, there is a global need to consider how to maximize treatment access for groups who are most affected by HCV. A substantial number of people who inject drugs ([...]

Plus d'info

Ajouter à la sélection